D-0259-2024 Class II Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

FDA drug recall D-0259-2024 was initiated by Glenmark Pharmaceuticals Inc., USA on Jan 4, 2024 and is designated Class II. Reason for recall: Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol The recall status is terminated (terminated Aug 16, 2024). Affected quantity: 38,496 bottles.

Recall Details

Product Type
Drugs
Report Date
Jan 31, 2024
Initiation Date
Jan 4, 2024
Termination Date
Aug 16, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
38,496 bottles

Product Description

Fluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Village: Kishanpura, Baddi Nalagarh Road, District: Solan, Himachal Pradesh - 173205, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-185-56

Reason for Recall

Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol

Distribution Pattern

USA Nationwide

Code Information

Lot #: 05220346, 05220369 Exp 1/31/ 2024; 05220582, Exp 2/29/2024; 05220861 Exp 3/31/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0259-2024
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.